Keyword: Mylan


Viatris Forms Eye Care Unit from Acquisitions

10.01.2023 -

Viatris, formed in November 2020 from the merger of Mylan with Pfizer’s Upjohn division, has established an eye care division following the closure of two acquisitions on...


Upjohn/Mylan Merger Closes to Form Viatris

26.11.2020 -

Pfizer has completed the spin-off of its Upjohn Business and combined it with Mylan to form Viatris, which began trading on Nov. 17. On closure of the deal, Pfizer...


Mylan Buys Aspen’s European Thrombosis Assets

21.09.2020 -

Mylan has agreed to buy the related intellectual property and commercialization rights of Aspen Pharmacare’s European thrombosis business for €641.9 million. The company...


Mylan Invests Again in Mapi’s MS Therapy

04.07.2020 -

US generics specialist Mylan is investing an additional $20 million in Mapi Pharma to support the latter’s ongoing Phase 3 clinical study and eventual commercialization...

Markets & Companies

Injecting Growth and Innovation

13.09.2019 - Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several...

Strategy & Management

Continuous Processing

10.09.2019 - Is it possible to learn from other industries or are we doomed to repeat the same mistakes in the pharma sector? Not long ago, I came across a Forbes article which described how...


Pfizer Merges Upjohn With Mylan

30.07.2019 - New York-based US drugs giant Pfizer is merging its off-patent franchise, Upjohn, with generics specialist Mylan. The deal announced on Jul. 29 and expected to close in mid-2020...


US States Sue Drugmakers Over Price-fixing

15.05.2019 - A coalition of 44 US states has filed a 500-page lawsuit against 20 leading generic drugmakers supplying the domestic market. The companies are accused of operating a sweeping...